Back to Search
LAWRENCE KEGELES, M.D.
M.D.
Psychiatry Physician
NPI: 1003037755Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
PMID 18418366·Neuropsychopharmacology·2008
8-other
Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders.
PMID 12505804·Am J Psychiatry·2003
3-trial
NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
PMID 11746730·Synapse·2002
8-other
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
PMID 11032974·Biol Psychiatry·2000
3-trial
Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.
PMID 10821999·Psychiatry Res·2000
8-other
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects.
PMID 19167701·Biol Psychiatry·2009
8-other
[11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects.
PMID 17311076·J Cereb Blood Flow Metab·2007
8-other
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635.
PMID 16953380·Psychopharmacology (Berl)·2006
8-other
Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
PMID 16177807·Neuropsychopharmacology·2006
7-preclinical
Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.
PMID 16198197·Clin Ther·2005
6-review
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum.
PMID 16018986·Biol Psychiatry·2005
4-observational
Altered prefrontal dopaminergic function in chronic recreational ketamine users.
PMID 16330601·Am J Psychiatry·2005
4-observational
Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates.
PMID 14960658·J Nucl Med·2004
7-preclinical
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide.
PMID 15121484·Biol Psychiatry·2004
4-observational
In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
PMID 15065219·Synapse·2004
4-observational
Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment.
PMID 14684442·Ann N Y Acad Sci·2003
6-review
Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohort.
PMID 14636962·Eur Neuropsychopharmacol·2003
4-observational
A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors.
PMID 14512213·Biol Psychiatry·2003
4-observational
Synthesis and in vivo evaluation of [11C]zolpidem, an imidazopyridine with agonist properties at central benzodiazepine receptors.
PMID 12767401·Nucl Med Biol·2003
7-preclinical
Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
PMID 12621304·J Cereb Blood Flow Metab·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1051 RIVERSIDE DRIVE, UNIT 31
NEW YORK, NY 10032 - Phone
- (212) 543-5497
Quick Facts
- NPI
- 1003037755
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile